<DOC>
	<DOC>NCT00205049</DOC>
	<brief_summary>The goal of this study is to demonstrate the effectiveness of pentoxifylline compared to placebo in AAH while studying putative mechanisms that are plausible and testable. The main hypothesis is that pentoxifylline reduces the 90-day mortality of AAH.</brief_summary>
	<brief_title>Pentoxifylline for Acute Alcoholic Hepatitis (AAH)</brief_title>
	<detailed_description>The goal of this study is to demonstrate the effectiveness of pentoxifylline compared to placebo in AAH while studying putative mechanisms that are plausible and testable. The main hypothesis is that pentoxifylline reduces the 90-day mortality of AAH. This study never moved forward due to funding issues.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Alcoholic</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>Inpatient with acute alcoholic hepatitis Model for EndStage Liver Disease (MELD) of 15 or greater Recent alcohol abuse Recent infection Other life threatening disease Severe coagulopathy Another nonalcoholic cause of liver disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>acute alcoholic hepatitis</keyword>
</DOC>